摘要 |
New antiphlogistic and analgesic agents are disclosed having the formulas (I) and (II). These new compounds have an improved inhibiting effect and/or less cytotoxicity as compared with the compounds known from the prior art. The disclosed compounds are remarkably suitable to prevent and/or treat diseases caused or aggravated by an increased activity of the phospholipase A2 enzyme, such as inflammations, allergies, asthma, psoriasis and endotoxin shock.
|